Markets SixWeek Rally Highlights Divergent Stock Performance in Portfolio Japan China Trade Chiefs Hold First Bilateral Talks Since Escalating Trade Dispute UK Bank Holiday Travel Hottest Day of Year May Boost Tourism but Disrupts Commute LNG Tankers and Oil Cargo Transit Strait of Hormuz Signaling Potential Easing of Regional Tensions REPLOID Group AG Faces Auditor Appointment Issues 2025 Annual Report Delayed Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Regulatory Blocker Mustang Bio Inc MBIO Q4 2024 Earnings Massive EPS Miss Amidst No Revenue DDOG Q1 2026 Earnings EPS Surprise of 1585 Fuels Modest Gains Castle Biosciences Q1 2026 Earnings Narrowly Beats EPS Estimates but Stock Declines RWAYI Q1 2026 Earnings EPS Misses Estimates as Portfolio Adjustments Pressure Results PKST Q1 2026 Earnings Significant EPS Miss Amid Challenging Real Estate Market BBNX Q1 2026 Earnings Narrow Beat on EPS Amid Limited Revenue Disclosure AZZ Inc Nudges Higher Maintains Position Above Key Support AMCON Distributing DIT Holds Steady at 8088 Neutral Ground or Pause Before a Move EverQuote EVER Edges Higher Consolidating Near Key Resistance Amid Sector Movements STRD Preferred Stock Holds Steady Near 7350 as Support and Resistance Levels Come into Focus Optex Systems Holdings OPXS Posts Modest Gains Amid Tight Trading Range Tyra Biosciences TYRA Q1 2026 Earnings Net Loss Slightly Wider Than Street Estimates PLMR Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Not Disclosed TBH Q4 2025 Earnings Massive EPS Miss Overshadowed by Stock Surge Wendys Q1 2026 Earnings EPS Beats Estimates by 241 as Stock Gains Annexon Inc ANNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline but No Revenue Yet Tenax Therapeutics Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Pipeline Progress Satellites and AI Deployed to Track UK Hedgehog Decline Highlighting Environmental Monitoring Opportunities 51Talk COE Q3 2025 Earnings Wider Loss Weighs on Shares as Revenue Details Remain Unclear Treace Medical Concepts TMCI Declines 211 as Stock Nears Key Support at 264